Ocean Biomedical, Inc. Quarterly Debt-to-equity in % from Q2 2022 to Q1 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Ocean Biomedical, Inc. quarterly Debt-to-equity history and growth rate from Q2 2022 to Q1 2024.
  • Ocean Biomedical, Inc. Debt-to-equity for the quarter ending March 31, 2024 was -104 %, a 15.1% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q1 2024 -104 -13.6 -15.1% Mar 31, 2024
Q4 2023 -103 -37.4 -56.7% Dec 31, 2023
Q3 2023 -103 -56.3 -121% Sep 30, 2023
Q2 2023 -99.8 -46 -85.4% Jun 30, 2023
Q1 2023 -90.2 Mar 31, 2023
Q4 2022 -65.8 Dec 31, 2022
Q3 2022 -46.4 Sep 30, 2022
Q2 2022 -53.8 Jun 30, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.